The Democratic Republic of the Congo (DRC) has received an initial allocation of 70,000 doses of the Ervebo Ebola vaccine to support the response to the...
The World Health Organisation (WHO) has recommended a Phase III trial of an Ebola vaccine to test whether it can protect against Bundibugyo virus disease. WHO...
The World Health Organisation (WHO) has recommended that a vaccine called Ervebo be prioritised for a randomised clinical trial against Bundibugyo virus disease in the Democratic...
The World Health Organisation (WHO) has recommended that a vaccine called Ervebo be prioritised for a randomised clinical trial against Bundibugyo virus disease in the Democratic...
The Ebola outbreak caused by the Bundibugyo virus in the Democratic Republic of the Congo (DRC) has intensified, with 3,605 confirmed cases and 1,587 deaths recorded...
The Democratic Republic of the Congo (DRC) has recorded 3,200 confirmed Ebola cases, including 1,405 deaths, as the outbreak continues to spread across six provinces, according...
The Coalition for Epidemic Preparedness Innovations (CEPI) has announced the start of the world’s first human clinical trial of a vaccine developed specifically against the Bundibugyo...
The Bundibugyo virus disease (BVD) outbreak in the Democratic Republic of the Congo remains active, with sustained transmission driving increases in reported cases and deaths. As...
The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda presents an urgent public health and development challenge for the Great Lakes...
The Africa Centres for Disease Control and Prevention (Africa CDC) has reported progress in efforts to contain the Ebola outbreak in the Democratic Republic of the...